Evotec SE (EVO) Current Assets (2009 - 2026)
Evotec SE (EVO) reported Current Assets of $832725.6 for Q1 2026, up 9.36% on a YoY basis from $761435.0 in Q1 2025, and down 6.24% sequentially from $888101.2 in Q4 2025.
Evotec SE (EVO) Current Assets (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Current Assets data on file, last reported at $832725.6 in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 9.36% year-over-year to $832725.6; the trailing twelve-month figure through Mar 2026 stood at $832725.6 (up 9.36% YoY), and the FY2025 full-year result was $888101.2, down 99.88% from the prior year.
- Current Assets fell to $832725.6 in Q1 2026, from $888101.2 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.1 billion in Q4 2022 to a low of $684208.5 in Q2 2025.
- A 5-year average of $233.7 million and a median of $912344.8 in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 49.12% in 2022 and plunged 99.88% in 2025, its largest moves.
- Tracing EVO's Current Assets over 5 years: stood at $1.1 billion in 2022, then declined by 11.29% to $971.7 million in 2023, then decreased by 25.01% to $728.7 million in 2024, then plunged by 99.88% to $888101.2 in 2025, then dropped by 6.24% to $832725.6 in 2026.
- Business Quant data shows EVO's Current Assets at $832725.6 in Q1 2026, $888101.2 in Q4 2025, and $927195.1 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 832,725.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 832,725.62 |
| Dec 31, 2025 | 888,101.18 |
| Sep 30, 2025 | 927,195.13 |
| Jun 30, 2025 | 684,208.51 |
| Mar 31, 2025 | 761,434.95 |
| Dec 31, 2024 | 728.74 Mn |
| Sep 30, 2024 | 766,665.94 |
| Mar 31, 2024 | 897,494.51 |
| Dec 31, 2023 | 971.75 Mn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 1.26 Bn |
| Sep 30, 2021 | 740,953.30 |
| Dec 31, 2020 | 785.53 Mn |
| Sep 30, 2010 | 104,385.19 |
| Jun 30, 2010 | 102,076.24 |
| Mar 31, 2010 | 91.56 |
| Dec 31, 2009 | 101,831.16 |
| Jun 30, 2009 | 104.72 Mn |